COUCH Health Publishes ‘Inclusive Terminology Report’ to Support Diversity in Clinical Trials
COUCH Health announced the publication of a new report “Exploring the Impact of Terminology on Inclusivity in Healthcare” as part of the Demand Diversity campaign.
The report was conducted and produced by the COUCH Health in-house research team, who consulted with 300 people from across a range of different groups to understand how they perceived terminology which is commonly found across healthcare and medical literature.
The initial phase of qualitative research was supplemented by quantitative research in the shape of a survey, which was co-designed with 20 people from across the UK and the US. The resulting research explores terminology across the following areas: disability, race and ethnicity, sexuality, and gender.
Access the full report here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
